查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504946

寡核苷酸合成市場、佔有率、規模、趨勢、產業分析報告：依產品、應用、地區、細分市場預測，2024-2032

Oligonucleotide Synthesis Market Share, Size, Trends, Industry Analysis Report, By Product (Synthesized Oligonucleotide Products, Equipment, Reagents, Equipment, and Services); By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球寡核苷酸合成市場規模預計將達到101.7億美元。本報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

寡核苷酸療法在治療視網膜疾病、癌症和心血管疾病等慢性疾病方面顯示出巨大潛力。各個生物技術領域寡核苷酸序列的不斷發展和新發現預計將推動市場擴張。寡核苷酸合成的一個重要的新興應用脫穎而出，特別是精準醫學中分子診斷的需求顯著增加。

用於基因表現分析的高通量定序和 CRISPR（成簇規則間隔短回文重複）等先進方法的整合將簡化基因組修飾和遺傳篩選，影響對寡核苷酸合成的需求。製造商回應對客製化寡核苷酸不斷成長的需求，並積極投資於技術開發，以提高準確性和產量，並促進寡核苷酸更長的生產。

支持寡核苷酸合成市場成長的關鍵因素是支持基因組進步的監管框架的存在。目的是為先進生物研究及其在人類中的應用創造明確環境的監管政策的預期變化將對寡核苷酸合成的需求產生重大影響。醫療保健領域，特別是幹細胞、再生醫學、基因工程和合成生物學，被認為是具有巨大潛力的關鍵領域。國際幹細胞研究學會（ISSCR）的道德與公共政策委員會就是一個例子。該委員會由道德、法律和社會政策領域的專家組成，在認識和解決相關問題方面發揮關鍵作用。

此外，市場受到嚴格的監管審查，尤其是基因組學的臨床應用，在許多國家都受到嚴格的監督和監管。一些司法管轄區允許基因研究用於非人類應用。監管政策預計將轉向為先進生物研究及其人類應用建立明確的框架，這將對寡核苷酸合成的需求產生重大影響。這些變化反映了監管環境的動態格局，影響市場的軌跡，並凸顯了不斷發展的基因組學領域對合規性和適應性的需求。

寡核苷酸合成市場報告亮點

由於基因組研究的日益普及，預計寡核苷酸合成產品產業將在2023年實現最高成長

在預測期內，PCR 引子區隔預計將主導寡核苷酸合成市場。這是由於基因表現檢測和測量的增加。

2023年，由於大公司的存在、技術進步以及對遺傳疾病認識的提高，北美地區佔據了最大的收入佔有率。

由於 ATDBio Ltd.、Bio-Synthesis Inc.、Biosearch Technologies、Eurofins Genomics 和 GE Healthcare 等全球市場參與者的存在，該市場競爭非常激烈。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球寡核苷酸合成市場洞察

  • 行業概況
  • 寡核苷酸合成市場動態
    • 推動因素和機會
      • 日益使用合成寡核苷酸在分子診斷和臨床應用中
      • 增加對製藥和生技公司的投資
    • 抑制因素和挑戰
      • 降低成本
  • PESTLE分析
  • 寡核苷酸合成產業的趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球寡核苷酸合成市場：依產品

  • 主要發現
  • 簡介
  • 合成寡核苷酸產品
  • 設備
  • 試劑
  • 服務

第6章 全球寡核苷酸合成市場：依應用劃分

  • 主要發現
  • 簡介
  • PCR 檢測與組合
  • PCR 引子
  • DNA 微陣列
  • 定序
  • 反義寡核苷酸
  • 螢光原位雜交（FISH）
  • 其他

第7章 全球寡核苷酸合成市場：依地區

  • 主要發現
  • 簡介
    • 寡核苷酸合成市場評估：依地區劃分，2019-2032年
  • 北美
    • 北美：依用途，2019-2032年
    • 北美：依產品分類，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依用途，2019-2032年
    • 歐洲：依產品分類，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依應用程式劃分，2019-2032年
    • 亞太地區：依產品分類，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東與非洲：依用途，2019-2032年
    • 中東與非洲：依產品分類，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依用途，2019-2032年
    • 拉丁美洲：依產品分類，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第9章 公司簡介

  • Agilent Technologies
  • ATDBio Ltd
  • Bio-Synthesis Inc.
  • Biosearch Technologies
  • Eurofins Genomics
  • GE Healthcare
  • Genewiz
  • GenScript Corporation
  • Integrated DNA Technologies（IDT）
  • LGC Biosearch Technologies
  • Merck KGaA（including Sigma-Aldrich）
  • Nitto Denko Avecia Inc.
  • Thermo Fisher Scientific
  • TriLink BioTechnologies
  • Twist Bioscience
Product Code: PM4917

The global oligonucleotide synthesis market size is expected to reach USD 10.17 billion by 2032, according to a new study by Polaris Market Research. The report "Oligonucleotide Synthesis Market Share, Size, Trends, Industry Analysis Report, By Product (Synthesized Oligonucleotide Products, Equipment, Reagents, Equipment, and Services); By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Oligonucleotide therapeutics exhibit substantial promise in addressing chronic conditions such as retinal disorders, cancers, and cardiovascular, among others. The continuous evolution and newfound implementation of oligo sequences across various biotechnological domains are anticipated to propel market expansion. A significant upsurge in demand for molecular diagnostics, especially in precision care, stands out as a crucial emerging application for oligonucleotide synthesis.

The integration of advanced methodologies such as high-throughput sequencing and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) for gene expression analysis has streamlined genome modification and genetic screening, thereby influencing the demand for oligonucleotide synthesis. Manufacturers are actively investing in technology development to facilitate the production of longer oligonucleotides with enhanced precision and higher yield, aligning with the increasing demand for customized oligos.

The pivotal driver behind oligonucleotide synthesis market growth lies in the presence of a regulatory framework supportive of genomic advancements. Anticipated changes in regulatory policies aimed at creating a well-defined environment for advanced biological research and its application in human use are poised to exert a substantial impact on the demand for oligonucleotide synthesis. Healthcare sectors, particularly in stem cells, regenerative medicine, genetic engineering, and synthetic biology, are identified as key areas with significant potential. An illustrative example is the International Society for Stem Cell Research (ISSCR) ethics and public policy committee, which endeavors to address concerns through transparent discussions. This committee, comprising global experts in ethics, law, and social policy, plays a vital role in recognizing and resolving pertinent issues.

Moreover, the market undergoes rigorous regulatory scrutiny, particularly in the clinical applications of genomics, where stringent monitoring and restrictions prevail in many countries. Some jurisdictions permit genetic research in non-human use sectors. Anticipated shifts in regulatory policies geared towards establishing a well-defined framework for advanced biological research and its application in human use are poised to exert a substantial impact on the demand for oligonucleotide synthesis. These changes reflect the dynamic landscape of regulatory considerations, affecting the market's trajectory and emphasizing the need for compliance and adaptability in the evolving field of genomics.

Oligonucleotide Synthesis Market Report Highlights

In 2023, the synthesized oligonucleotide products segment is expected to witness highest growth during forecast period owing to increased prevalence of genomic studies

PCR primers segment is expected to dominate the oligonucleotide synthesis market during forecast period. This is attributed to increase in detecting and measuring gene expression

In 2023, North America accounted for the largest revenue share due to presence of major players, technological advancements, and growing awareness of genetic disorders.

The market is highly competitive owing to the existence of market players with a global presence, including ATDBio Ltd., Bio-Synthesis Inc., Biosearch Technologies, Eurofins Genomics, GE Healthcare, among others.

Polaris Market Research has segmented the oligonucleotide synthesis market report based on product, application, and region:

Oligonucleotide Synthesis, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Synthesized Oligonucleotide Products
  • Equipment
  • Reagents
  • Services

Oligonucleotide Synthesis, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • PCR Assays and Panels
  • PCR Primers
  • DNA Microarrays
  • Sequencing
  • Antisense Oligonucleotides
  • Fluorescence In Situ Hybridization (FISH)
  • Others

Oligonucleotide Synthesis, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LA
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oligonucleotide Synthesis Market Insights

  • 4.1. Oligonucleotide Synthesis Market - Industry Snapshot
  • 4.2. Oligonucleotide Synthesis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • 4.2.1.2. Increased investment in pharmaceutical and biotechnology companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Erosion of costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Oligonucleotide Synthesis Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oligonucleotide Synthesis Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oligonucleotide Synthesis, by Product, 2019-2032 (USD Billion)
  • 5.3. Synthesized Oligonucleotide Products
    • 5.3.1. Global Oligonucleotide Synthesis Market, by Synthesized Oligonucleotide Products, by Region, 2019-2032 (USD Billion)
  • 5.4. Equipment
    • 5.4.1. Global Oligonucleotide Synthesis Market, by Equipment, by Region, 2019-2032 (USD Billion)
  • 5.5. Reagents
    • 5.5.1. Global Oligonucleotide Synthesis Market, by Reagents, by Region, 2019-2032 (USD Billion)
  • 5.6. Services
    • 5.6.1. Global Oligonucleotide Synthesis Market, by Services, by Region, 2019-2032 (USD Billion)

6. Global Oligonucleotide Synthesis Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • 6.3. PCR Assays and Panels
    • 6.3.1. Global Oligonucleotide Synthesis Market, by PCR Assays and Panels, by Region, 2019-2032 (USD Billion)
  • 6.4. PCR Primers
    • 6.4.1. Global Oligonucleotide Synthesis Market, by PCR Primers, by Region, 2019-2032 (USD Billion)
  • 6.5. DNA Microarrays
    • 6.5.1. Global Oligonucleotide Synthesis Market, by DNA Microarrays, by Region, 2019-2032 (USD Billion)
  • 6.6. Sequencing
    • 6.6.1. Global Oligonucleotide Synthesis Market, by Sequencing, by Region, 2019-2032 (USD Billion)
  • 6.7. Antisense Oligonucleotides
    • 6.7.1. Global Oligonucleotide Synthesis Market, by Antisense Oligonucleotides, by Region, 2019-2032 (USD Billion)
  • 6.8. Fluorescence In Situ Hybridization (FISH)
    • 6.8.1. Global Oligonucleotide Synthesis Market, by Fluorescence In Situ Hybridization (FISH), by Region, 2019-2032 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Oligonucleotide Synthesis Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Oligonucleotide Synthesis Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Oligonucleotide Synthesis Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Oligonucleotide Synthesis Market - North America
    • 7.3.1. North America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.3.2. North America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.3.3. Oligonucleotide Synthesis Market - U.S.
      • 7.3.3.1. U.S.: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.3.4. Oligonucleotide Synthesis Market - Canada
      • 7.3.4.1. Canada: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.4. Oligonucleotide Synthesis Market - Europe
    • 7.4.1. Europe: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.3. Oligonucleotide Synthesis Market - UK
      • 7.4.3.1. UK: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.4. Oligonucleotide Synthesis Market - France
      • 7.4.4.1. France: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.5. Oligonucleotide Synthesis Market - Germany
      • 7.4.5.1. Germany: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.6. Oligonucleotide Synthesis Market - Italy
      • 7.4.6.1. Italy: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.7. Oligonucleotide Synthesis Market - Spain
      • 7.4.7.1. Spain: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.8. Oligonucleotide Synthesis Market - Netherlands
      • 7.4.8.1. Netherlands: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.4.9. Oligonucleotide Synthesis Market - Russia
      • 7.4.9.1. Russia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.5. Oligonucleotide Synthesis Market - Asia Pacific
    • 7.5.1. Asia Pacific: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.3. Oligonucleotide Synthesis Market - China
      • 7.5.3.1. China: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.4. Oligonucleotide Synthesis Market - India
      • 7.5.4.1. India: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.5. Oligonucleotide Synthesis Market - Malaysia
      • 7.5.5.1. Malaysia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.6. Oligonucleotide Synthesis Market - Japan
      • 7.5.6.1. Japan: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.7. Oligonucleotide Synthesis Market - Indonesia
      • 7.5.7.1. Indonesia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.5.8. Oligonucleotide Synthesis Market - South Korea
      • 7.5.8.1. South Korea: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.6. Oligonucleotide Synthesis Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.3. Oligonucleotide Synthesis Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.4. Oligonucleotide Synthesis Market - UAE
      • 7.6.4.1. UAE: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.5. Oligonucleotide Synthesis Market - Israel
      • 7.6.5.1. Israel: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.6.6. Oligonucleotide Synthesis Market - South Africa
      • 7.6.6.1. South Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • 7.7. Oligonucleotide Synthesis Market - Latin America
    • 7.7.1. Latin America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.7.3. Oligonucleotide Synthesis Market - Mexico
      • 7.7.3.1. Mexico: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.7.4. Oligonucleotide Synthesis Market - Brazil
      • 7.7.4.1. Brazil: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
    • 7.7.5. Oligonucleotide Synthesis Market - Argentina
      • 7.7.5.1. Argentina: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Agilent Technologies
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ATDBio Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Bio-Synthesis Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Biosearch Technologies
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Eurofins Genomics
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. GE Healthcare
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Genewiz
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. GenScript Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Integrated DNA Technologies (IDT)
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. LGC Biosearch Technologies
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Merck KGaA (including Sigma-Aldrich)
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Nitto Denko Avecia Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Thermo Fisher Scientific
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. TriLink BioTechnologies
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Twist Bioscience
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development

List of Tables

  • Table 1 Global Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Oligonucleotide Synthesis Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 5 North America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 6 U.S.: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 7 U.S.: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 8 Canada: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 9 Canada: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 10 Europe: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Europe: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 12 UK: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 13 UK: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 14 France: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 15 France: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Germany: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 17 Germany: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 18 Italy: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 19 Italy: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Spain: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Spain: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Russia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Russia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 28 China: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 29 China: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 30 India: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 31 India: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Japan: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Japan: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 38 South Korea: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 39 South Korea: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 44 UAE: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 45 UAE: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 46 Israel: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Israel: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 48 South Africa: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 49 South Africa: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Latin America: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Latin America: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Mexico: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Mexico: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Brazil: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Brazil: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Argentina: Oligonucleotide Synthesis Market, by Application, 2019-2032 (USD Billion)
  • Table 57 Argentina: Oligonucleotide Synthesis Market, by Product, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Oligonucleotide Synthesis Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Oligonucleotide Synthesis Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Product
  • Figure 9 Global Oligonucleotide Synthesis Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10 Oligonucleotide Synthesis Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Oligonucleotide Synthesis Market